Details of the Drug Formulations

General Information of Drug (ID: DM8RFNJ)

Drug Name
Pitolisant Drug Info
Synonyms
Pitolisant; 362665-56-3; TIPROLISANT; BF2.649; UNII-4BC83L4PIY; 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine; Pitolisant (BF2.649); 1-(3-(3-(4-Chlorophenyl)propoxy)propyl)piperidine; 4BC83L4PIY; Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-; CHEMBL462605; wakix; 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride; 1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine; Tirolisant; Pitolisant (INN); tiprolisant [USAN]; Wakix (TN); Pitolisant [USAN:INN]; SCHEMBL117648; GTPL8924; CTK1B6404; HBS-101
Indication
Disease Entry ICD 11 Status REF
Excessive daytime sleepiness MG42 Approved [1]
Schizophrenia 6A20 Phase 3 [2]
Cross-matching ID
PubChem CID
9948102
ChEBI ID
CHEBI:134709
CAS Number
362665-56-3
TTD ID
D01UUD
ACDINA ID
D01345

Full List of Drug Formulations Containing This Drug

Pitolisant 17.8 mg tablet
Company Formulation ID FDA Description
Harmony Biosciences F24345 Colloidal Silicon Dioxide; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol; Polyvinyl Alcohol; Talc; Titanium Dioxide
------------------------------------------------------------------------------------
Pitolisant 4.45 mg tablet
Company Formulation ID FDA Description
Harmony Biosciences F24388 Colloidal Silicon Dioxide; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol; Polyvinyl Alcohol; Talc; Titanium Dioxide
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 ClinicalTrials.gov (NCT01800045) Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP). U.S. National Institutes of Health.